NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Deborah Wenkert, MD

Practice Area Focus

  • Drugs
  • Biologics
  • Pediatric Drugs
  • Orphan Designation
  • Clinical Trial Design
  • Clinical Development Strategy
  • Pediatric Trials


Dr. Deborah Wenkert joined NDA Partners as an Expert Consultant in 2016. She is an expert in pediatrics, rheumatology, and bone disease, and formerly a Clinical Research Medical Director within the therapeutic areas of inflammation and bone at Amgen.

Following an immunology postdoc at Harvard University, Dr. Wenkert was a faculty member at Washington University School of Medicine and then, for eleven years, at St Louis University School of Medicine in the division of rheumatology. Concurrent with her position at St. Louis University, Dr. Wenkert conducted research in adult and pediatric metabolic and genetic disorders and provided care to affected children as the Associate Director of the Center for Metabolic Bone Disease and Molecular Research.

Dr. Wenkert is board certified in pediatrics and pediatric rheumatology and is a Fellow of the American Academy of Pediatrics and American College of Rheumatology, and a member of the American Society for Bone and Mineral Research.